Trial Profile
A study assessing antibody response after immunization with Plasmodium falciparum (Pf) sporozoites (SPZ) (Sanaria® PfSPZ Vaccine)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2018
Price :
$35
*
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Falciparum malaria
- Focus Pharmacodynamics
- 16 Feb 2018 New trial record
- 08 Feb 2018 Results published in the Journal of Infectious Diseases